Patents by Inventor Juergen Gamer

Juergen Gamer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination of CD95/CD95L inhibition and Cancer Immunotherapy
    Publication number: 20170106048
    Abstract: The present invention relates to the treatment of cancer using a combination of an inhibitor of the CD95/CD95L signaling system and an immunotherapeutic agent, e.g. a cancer vaccine or a checkpoint inhibitor. Another aspect of the invention is the prognosis of responsiveness of a cancer to the treatment with a combination of a CD95 inhibitor and an immunotherapeutic agent. Further disclosed are preparations and kits for use in these methods.
    Type: Application
    Filed: December 23, 2016
    Publication date: April 20, 2017
    Inventors: Claudia KUNZ, Harald FRICKE, Thomas HÖGER, Juergen GAMER
  • ANTIBODY SPECIFIC FOR HUMAN IL-4 FOR THE TREATMENT OF CANCER
    Publication number: 20100297110
    Abstract: The present invention relates to the use of an antibody or an antigen-binding fragment thereof with specific binding activity for human interleukin-4 for the prevention and/or treatment of cancer.
    Type: Application
    Filed: March 21, 2007
    Publication date: November 25, 2010
    Applicant: APOGENIX GMBH
    Inventors: Thomas Hoeger, Juergen Gamer, Giorgio Stassi, Matilde Todaro
  • HUMAN IL-4 MUTEINS IN CANCER THERAPY
    Publication number: 20100086515
    Abstract: The present invention relates to the use of a combination of human interleukin-4 muteins and chemotherapeutic or pro-apoptotic agents for the prevention and/or treatment of cancer disease.
    Type: Application
    Filed: July 6, 2007
    Publication date: April 8, 2010
    Applicant: APOGENIX GMBH
    Inventors: Thomas Höger, Jürgen Gamer